1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pressure Contact Activated Safety Lancet Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pressure Contact Activated Safety Lancet Market Revenue and Volume, by Product Type
8.1.1. Fixed-Depth Pressure-Activated Lancets
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Adjustable-Depth Pressure-Activated Lancets
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Neonatal/Pediatric Pressure-Activated Lancets
8.1.3.1. Market Revenue and Volume Forecast
9.1. Pressure Contact Activated Safety Lancet Market Revenue and Volume, by Activation Mechanism
9.1.1. Single-Pressure Contact Activation
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Spring-Loaded Auto-Trigger Mechanism
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Pressure-Activated with Lockout Feature
9.1.3.1. Market Revenue and Volume Forecast
10.1. Pressure Contact Activated Safety Lancet Market Revenue and Volume, by Application
10.1.1. Blood Glucose Monitoring (SMBG)
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hemoglobin & Cholesterol Testing
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Infectious Disease Testing
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Neonatal & Pediatric Screening
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Other Point-of-Care Diagnostics
10.1.5.1. Market Revenue and Volume Forecast
11.1. Pressure Contact Activated Safety Lancet Market Revenue and Volume, by End-User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Clinics & Physician Offices
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Home Healthcare/Self-Testing Users
11.1.4.1. Market Revenue and Volume Forecast
12.1. Pressure Contact Activated Safety Lancet Market Revenue and Volume, by Distribution Channel
12.1.1. Hospital & Institutional Procurement
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Retail/Pharmacy Distribution
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Online/E-Commerce Platforms
12.1.3.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product Type
13.1.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.1.3. Market Revenue and Volume Forecast, by Application
13.1.4. Market Revenue and Volume Forecast, by End-User
13.1.5. Market Revenue and Volume Forecast, by Distribution Channel
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product Type
13.1.6.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.1.6.3. Market Revenue and Volume Forecast, by Application
13.1.6.4. Market Revenue and Volume Forecast, by End-User
13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product Type
13.1.7.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.1.7.3. Market Revenue and Volume Forecast, by Application
13.1.7.4. Market Revenue and Volume Forecast, by End-User
13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product Type
13.2.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.2.3. Market Revenue and Volume Forecast, by Application
13.2.4. Market Revenue and Volume Forecast, by End-User
13.2.5. Market Revenue and Volume Forecast, by Distribution Channel
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product Type
13.2.6.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.2.6.3. Market Revenue and Volume Forecast, by Application
13.2.7. Market Revenue and Volume Forecast, by End-User
13.2.8. Market Revenue and Volume Forecast, by Distribution Channel
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product Type
13.2.9.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.2.9.3. Market Revenue and Volume Forecast, by Application
13.2.10. Market Revenue and Volume Forecast, by End-User
13.2.11. Market Revenue and Volume Forecast, by Distribution Channel
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product Type
13.2.12.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.2.12.3. Market Revenue and Volume Forecast, by Application
13.2.12.4. Market Revenue and Volume Forecast, by End-User
13.2.13. Market Revenue and Volume Forecast, by Distribution Channel
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product Type
13.2.14.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.2.14.3. Market Revenue and Volume Forecast, by Application
13.2.14.4. Market Revenue and Volume Forecast, by End-User
13.2.15. Market Revenue and Volume Forecast, by Distribution Channel
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product Type
13.3.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.3.3. Market Revenue and Volume Forecast, by Application
13.3.4. Market Revenue and Volume Forecast, by End-User
13.3.5. Market Revenue and Volume Forecast, by Distribution Channel
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product Type
13.3.6.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.3.6.3. Market Revenue and Volume Forecast, by Application
13.3.6.4. Market Revenue and Volume Forecast, by End-User
13.3.7. Market Revenue and Volume Forecast, by Distribution Channel
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product Type
13.3.8.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.3.8.3. Market Revenue and Volume Forecast, by Application
13.3.8.4. Market Revenue and Volume Forecast, by End-User
13.3.9. Market Revenue and Volume Forecast, by Distribution Channel
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product Type
13.3.10.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.3.10.3. Market Revenue and Volume Forecast, by Application
13.3.10.4. Market Revenue and Volume Forecast, by End-User
13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product Type
13.3.11.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.3.11.3. Market Revenue and Volume Forecast, by Application
13.3.11.4. Market Revenue and Volume Forecast, by End-User
13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product Type
13.4.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.4.3. Market Revenue and Volume Forecast, by Application
13.4.4. Market Revenue and Volume Forecast, by End-User
13.4.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product Type
13.4.6.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.4.6.3. Market Revenue and Volume Forecast, by Application
13.4.6.4. Market Revenue and Volume Forecast, by End-User
13.4.7. Market Revenue and Volume Forecast, by Distribution Channel
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product Type
13.4.8.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.4.8.3. Market Revenue and Volume Forecast, by Application
13.4.8.4. Market Revenue and Volume Forecast, by End-User
13.4.9. Market Revenue and Volume Forecast, by Distribution Channel
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product Type
13.4.10.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.4.10.3. Market Revenue and Volume Forecast, by Application
13.4.10.4. Market Revenue and Volume Forecast, by End-User
13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product Type
13.4.11.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.4.11.3. Market Revenue and Volume Forecast, by Application
13.4.11.4. Market Revenue and Volume Forecast, by End-User
13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product Type
13.5.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.5.3. Market Revenue and Volume Forecast, by Application
13.5.4. Market Revenue and Volume Forecast, by End-User
13.5.5. Market Revenue and Volume Forecast, by Distribution Channel
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product Type
13.5.6.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.5.6.3. Market Revenue and Volume Forecast, by Application
13.5.6.4. Market Revenue and Volume Forecast, by End-User
13.5.7. Market Revenue and Volume Forecast, by Distribution Channel
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product Type
13.5.8.2. Market Revenue and Volume Forecast, by Activation Mechanism
13.5.8.3. Market Revenue and Volume Forecast, by Application
13.5.8.4. Market Revenue and Volume Forecast, by End-User
13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel
14.1. Roche Diagnostics
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Becton, Dickinson and Company (BD)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. HTL-STREFA (MTD Medical Technology and Devices)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Owen Mumford
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Greiner Bio-One International GmbH
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Sarstedt AG & Co. KG
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. McKesson Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Medline Industries, LP
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Cardinal Health
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Smiths Medical
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client